Fasinumab in the treatment of hip and knee osteoarthritic pain: efficacy and safety in a 36-week randomized, double-blind placebo-controlled clinical trial
2017 ◽
Vol 25
◽
pp. S56-S57
◽
2019 ◽
Vol 45
◽
pp. 262-268
◽
Keyword(s):
2019 ◽
Vol 73
(11)
◽
pp. 690-696
◽
Keyword(s):
2010 ◽
Vol 7
(8)
◽
pp. 2842-2850
◽